The standard treatment for men with advanced prostate cancer is androgen-deprivation therapy. Androgens are hormones that fuel prostate cell growth; removing them with either drugs or surgery causes ...

Prostate cancer is the most common visceral malignancy and the second leading cause of cancer death among U.S. males, with over 29,000 deaths in 2004 attributable to this disease. Age is the strongest ...

Researchers have discovered that prostate cancer depends on two key enzymes, PDIA1 and PDIA5, to survive and resist therapy.

Scientists have uncovered a critical weakness in prostate cancer’s defences. The disease relies on two enzymes, PDIA1 and ...

This fluorescent microscopy image shows massive cell division occurring in the mouse prostate gland. Dividing cells are red, luminal cells are green, and basal cells are white. Summary The prostate ...

High-intensity-focused ultrasound (HIFU) can treat some men with prostate cancer as an alternative to surgery or radiation therapy. The corresponding study was published in The Lancet. "We believe ...

Prostate cancer is the second most common form of cancer among men in the world. When detected early, the disease is usually ...

Samantha Berlin is a Newsweek reporter based in New York. Her focus is reporting on trends and human-interest stories. Samantha joined Newsweek in 2021. She is a graduate of Syracuse University's S.I.

Men suffering from an enlarged prostate can receive long-term relief from a minimally invasive procedure that partially blocks blood flow to the gland, new research reports. The procedure, called ...

Prostate cancer is the second-leading cause of cancer-associated death in men after lung cancer. Prostate cancer is highly common in which 1 in 8 men will be diagnosed with the disease in their ...

The prostate gland has a remarkable ability to regrow itself after hormone-deprivation therapy. A new study from researchers at Memorial Sloan Kettering explains why. The standard treatment for men ...